Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK

5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK

Longeveron Inc. (NASDAQ: LGVN) announced in July 2024 that the FDA granted Fast Track designation for its cellular therapy, Lomecel-B™, aimed at treating mild Alzheimer's Disease, accelerating its clinical development. The therapy also received RMAT designation, and the company announced a $9 million registered direct offering managed by H.C. Wainwright & Co.

Peraso Inc. (NASDAQ: PRSOa leader in mmWave technology for 5G and 60 GHz networks, announced preliminary Q2 revenues of approximately $4.2 million, ending June 30, 2024, exceeding prior guidance. This represents a 50% sequential and 70% year-on-year growth. The stock has been trending upward, with investors anticipating it may rise above the 200 DMA and potentially challenge its three-month high of $2.04.

SiriusXM (NASDAQ: SIRIreported year-on-year revenues at $2.16 billion, beating analysts' forecasts by 1.4%. The stock has surged from a multiyear low in the past month, likely due to a short squeeze ahead of its anticipated merger with Liberty Sirius XM Holdings, Read more.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced in July 2024, 3 new UK major manufacturers, have adopted its "Fingerprint Drug Screening System" for fast, reliable drug detection from fingertip sweat. Additionally, the system's successful biocompatibility testing advances it toward FDA 510(k) clearance, aiming for US market entry in 2025.

Catheter Precision (NYSE American: VTAK) implemented a new share structure on July 15, 2024, ensuring equal impact on shareholders. The company received evaluations and orders for its LockeT product from institutions such as UCLA Ronald Reagan Medical Center and HCA Healthcare. Their expansion strategy involves first introducing LockeT products to establish credibility, followed by the rollout of VIVO products. Additionally, the patient follow-up phase for the VIVO European Registry concluded in June 2023.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.